> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Safety-Related Gocovri Labeling Changes Approved
- URL: https://www.fdaweb.com/safety-related-gocovri-labeling-changes-approved/
- Published: 2021-02-03T12:00:00.000Z
- Updated: 2026-09-14T16:45:16.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148583

FDA has approved safety-related labeling changes for Adamas Pharmaceuticals Parkinson’s drug Gocovri (amantadine HCl). The [changes](https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?DrugNameID=2213&event=searchdetail.page&utm%5Fmedium=email&utm%5Fsource=govdelivery) involve adding a postmarketing experience subsection to the Adverse Reactions section of the label and revising the Patient Counseling Information/Patient Information/Medication Guide.